512
Participants
Start Date
August 31, 2010
Primary Completion Date
June 30, 2012
Study Completion Date
December 31, 2012
BMS-790052
Film coated tablet, Oral, 20 mg, once daily, 24 weeks
BMS-790052
Film coated Tablet, Oral, 60 mg, once daily (divided dose taken BID), 48 weeks
Placebo
Film coated tablet, Oral, 0mg, Once daily, 24 weeks
peginterferon alfa-2a
Solution for injection, Subcutaneous injection, 180 µg, weekly, 24 or 48 weeks
ribavirin
Film coated tablet, Oral, 1,000 or 1,200 mg based on weight, divided dose taken twice a day (BID), 48 weeks
Local Institution, Prov de Santa Fe
Local Institution, Randwick
Local Institution, Hvidovre
Local Institution, Prahan
Local Institution, Heidelberg
Local Institution, Clayton
Local Institution, Odense
Local Institution, Perth
Local Institution, Fremantle
Local Institution, Aarhus
James J Peters Vamc, The Bronx
James Sungsik Park, M.D. C.N.S.C., Great Neck
Samuel S. Stratton Vamc, Albany
Upper Delaware Valley Infectious Diseases, Pc, Monticello
Local Institution, Stockholm
University Of Rochester Medical Center, Rochester
University Of Pennsylvania, Philadelphia
Local Institution, Hamburg
Johns Hopkins Medical Institutions, Lutherville
Mercy Medical Center, Baltimore
Digestive Disease Associates, P.A., Baltimore
Metropolitan Research, Fairfax
Local Institution, Pavia
Carolinas Center For Liver Disease, Statesville
Local Institution, Hanover
Miami Research Associates, South Miami
Alabama Liver & Digestive Specialists (Alds), Montgomery
Nashville Medical Research Institute, Nashville
Local Institution, Guadalajara
Local Institution, Essen
Indiana University, Indianapolis
Dean Clinic, Madison
Local Institution, Vandœuvre-lès-Nancy
Local Institution, Cisanello (pisa)
Local Institution, Frankfurt
Local Institution, Cuernavaca
Saint Louis University, St Louis
Local Institution, Monterrey
Local Institution, Lyon
Ochsner Clinic Foundation, New Orleans
Healthcare Research Consultants, Tulsa
Local Institution, Paris
Local Institution, Paris
North Texas Research Institute, Arlington
Liver Associates Of Texas, Houston
St. Luke'S Episcopal Hospital - Baylor College Of Medicine, Houston
Alamo Medical Research, San Antonio
Transplant Center And Hepatology Clinic, B-154, Aurora
CLI, Los Angeles
Scripps Clinic, La Jolla
Desta Digestive Disease Medical Center, San Diego
Local Institution, Clichy
Local Institution, Créteil
University Of California At San Francisco, San Francisco
California Pacific Medical Center, San Francisco
Kaiser Permanente Medical Center, San Francisco
Yale University School Of Medicine, New Haven
University Of Florida Hepatology, Gainesville
The Research Institute, Springfield
University Of North Carolina, Chapel Hill, Chapel Hill
University Gastroenterology, Providence
Local Institution, Ciudad de Buenos Aires
Local Institution, Ciudad de Buenos Aires
Local Institution, Edmonton
Local Institution, Vancouver
Local Institution, Victoria
Local Institution, Toronto
Local Institution, Toronto
Local Institution, Nice
Instituto De Investigacion Cientifica Del Sur, Ponce
Local Institution, San Juan
Local Institution, Gothenburg
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY